MedPath

Skin Safety study on Healthy human subjects with sensitive ski

Not Applicable
Completed
Registration Number
CTRI/2017/09/009741
Lead Sponsor
Dabur India Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
24
Inclusion Criteria

1 Healthy male and female subjects (in 1:1 ratio) in the age group of 18-55 years (both age inclusive) with sensitive skin

2 Subjects representing with normal, oily, dry and combination skin type in equal ratio

3 Subjects in good general health

4 Subjects with Fitzpatrick skin phototype III to V

5 Subjects scoring greater than 30 for Section 2- Sensitive v/s Resistant skin in modified Dr. Baumannâ??s skin type questionnaire

6 Subjects who agree not to carry bleaching or any other procedures including waxing during the study period

7 Subjects able to read, understand and willing to give a voluntary written informed consent

8 Subjects willing to maintain the test patches in designated positions for a particular time duration 30 mins

9 Subjects not having participated in a similar or any other clinical trial in the past four weeks

10 Subjects willing to come for regular follow up visits

11 Subjects ready to follow instructions during the study period

12 Female subjects with child bearing potential willing to undergo Urine Pregnancy Test

13 Subjects free from excessive hair, cuts, wounds, irritation symptoms, abrasion or any other skin condition which may interfere in the study results

Exclusion Criteria

1 Subjects with known hypersensitivity to any of the study products or constituents

2 Subjects with any significant skin pathology in the investigational area

3 Subjects using any topical or systemic treatment that could interfere with the study treatments/assessments within the last 4 weeks prior to participation in the study and during the study

4 Subjects who are athletes and have a history of excessive sweating

5 Female subjects who are pregnant and lactating

5 Subjects with any significant medical condition that would interfere with the participation in the trial

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath